Valneva SE: Vaccine Candidates With Blockbuster Potential!

Valneva SE (i.) is a European biotechnology company that specializes in vaccines for diseases such as Japanese encephalitis, cholera, or the chikungunya virus. I find it particularly interesting that they focus on infectious diseases with high unmet needs, where they are the only or one of very few vaccine providers. This was evidenced on March 24 when the chikungunya outbreak on a French island led the French authorities to order 40,000 vaccine doses with potential expansion options from Valneva. The outlook on the pipeline also looks positive,...